Mainz Biomed Nv earnings were -$21.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest MYNZ earnings report on Dec 31, 2024 announced Q4 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MYNZ reported annual earnings of -$21.7M, with -17.7% growth. The next MYNZ earnings date is Sep 3, 2025.
What were Mainz Biomed Nv's earnings last quarter?
Mainz Biomed Nv (NASDAQ: MYNZ) reported Q4 2024 earnings per share (EPS) of N/A, up N/A year over year. Total MYNZ earnings for the quarter were N/A. In the same quarter last year, Mainz Biomed Nv's earnings per share (EPS) was -$9.56.
The next MYNZ earnings call is Invalid Date. Add MYNZ to your watchlist to be reminded of Mainz Biomed Nv's next earnings date.
Is Mainz Biomed Nv profitable or losing money?
As of the last Mainz Biomed Nv earnings report, Mainz Biomed Nv is currently losing money. Mainz Biomed Nv's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$21.65 million, a 17.66% decrease year over year.
What was MYNZ's earnings growth in the past year?
As of Mainz Biomed Nv's earnings date in Q3 2025, Mainz Biomed Nv's earnings has grown year over year. MYNZ earnings in the past year totalled -$21.65 million.
What are Mainz Biomed Nv's earnings expectations?
The current EPS estimate for Mainz Biomed Nv's earnings report in Invalid Date is -$2.40.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.